Roche launches PHESGO for HER-2 positive breast cancer treatment in India
Roche Pharma on Thursday announced the India launch of PHESGO which is the world’s first-ever fixed-dose formulation in the history of cancer treatment to combine two monoclonal antibodies. The formulation is composed of antibodies Perjeta…